Live Marvell Technology Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow HeartSciences Inc.

Get SEC filing alerts via email and in your feed for HeartSciences Inc.

HSCS HSCSW

HeartSciences Inc.

About HeartSciences Inc.

HeartSciences Inc. develops AI-driven ECG solutions to enhance cardiac screening and diagnosis. Its core products include the MyoVista wavECG device and a cloud-based platform hosting AI-ECG algorithms for detecting heart dysfunction. Targeting healthcare settings worldwide, the company aims to improve early heart disease detection, expand ECG capabilities, and facilitate regulatory approval, offering a competitive, device-agnostic approach to cardiovascular diagnostics.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from HeartSciences Inc.

1
1
HeartSciences Inc. HeartSciences Reports Q3 Fiscal 2026 Net Loss of $1.99 Million, Revenue Growth for Nine Months

Via official filing (AI summary) | 3 months ago | 0 comments

2
1
HeartSciences Inc. HeartSciences Reports Modest Revenue Growth Amid Continued Losses in Q2 Fiscal 2026

Via official filing (AI summary) | 6 months ago | 0 comments

3
1
HeartSciences Inc. HeartSciences Reports Modest Revenue Growth and Increased Net Loss for Quarter Ending July 31, 2025

Via official filing (AI summary) | 9 months ago | 0 comments

4
1
HeartSciences Inc. HeartSciences Reports 77% Revenue Decline and $8.8 Million Net Loss for Fiscal Year Ending April 30, 2025

Via official filing (AI summary) | 11 months ago | 0 comments

5
1
HeartSciences Inc. HeartSciences Inc. Reports No Revenue and Increased Losses in Latest 10-Q Filing

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
HeartSciences Inc. HeartSciences Reports $4.1 Million Net Loss and Seeks Additional Funding

Via official filing (AI summary) | over 1 year ago | 0 comments

7
1
HeartSciences Inc. HeartSciences Reports Decrease in Cash and Cash Equivalents, Net Loss Increase in Latest Quarter

Via official filing (AI summary) | over 1 year ago | 0 comments